Treatment Options for Early-Stage Lung Cancer
Highlights modern surgical approaches, stereotactic radiation, bronchoscopic ablative trials, patient selection, and perioperative optimization for early-stage disease.
Track your progress—Treatment Options for Early-Stage Lung Cancer will stay highlighted in the catalog.
Exam mapping & scope
This chapter covers the contemporary management of resectable and medically inoperable stage I-II non-small cell lung cancer (NSCLC), aligned to AABIP board domains: (1) patient selection and pre‑operative evaluation; (2) surgical options (lobectomy, segmentectomy, wedge; minimally invasive approaches; nodal assessment); (3) stereotactic body radiation therapy (SBRT); (4) perioperative systemic therapy (neoadjuvant, adjuvant, peri‑adjuvant immunotherapy; adjuvant targeted therapy); (5) image‑guided ablation; (6) complications and surveillance.
Focus this round
- Shared decision making
- Ablative pathways
- Perioperative optimization
Interactive chapter
Expand sections to review focused notes. Search filters headings and body copy in real time.